C
CytoReason
About
CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of drug approval. To date, five of the world’s top ten pharma companies use CytoReason’s technology.
Tags
Total Employees
121
Current headcount
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
54Traction
60Team
70Visibility
31Profile
80Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does CytoReason do?
CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of drug approval. To date, five of the world’s top ten pharma companies use CytoReason’s technolog…
How much funding has CytoReason raised?
CytoReason has raised a total of $128M in funding. The most recent round on record is Series B.
When was CytoReason founded?
CytoReason was founded in 2016.
What industry does CytoReason operate in?
CytoReason operates in Healthcare, Drug Discovery, Clinical Development, Biomarkers, Target Discovery, Combination Selection.
How many employees does CytoReason have?
CytoReason has approximately 121 people on record.